Matrix metalloproteinases and their inhibitors in non-neoplastic otorhinolaryngological disease

Journal of Laryngology and Otology

Volumn 119, Issue 6, 2005, Pages 436-442

  De, S ^a,b   Fenton, J E ^a   Jones, A S ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Matrix metalloproteinases; Otorhinolaryngological diseases

Indexed keywords

ALPHA INTERFERON; CHEMOKINE; CHEMOKINE RECEPTOR; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 4; COLLAGENASE; COLLAGENASE 3; CYTOKINE; DODECYL SULFATE SODIUM; ELASTIN; ENDOTOXIN; ENZYME PRECURSOR; EOSINOPHIL CATIONIC PROTEIN; EPIDERMAL GROWTH FACTOR; FIBRONECTIN; GELATINASE; GELATINASE A; GELATINASE B; GLUCOCORTICOID; GROWTH FACTOR; ILOMOSTAT; INTERLEUKIN 1; INTERSTITIAL COLLAGENASE; LAMININ; LEUKOCYTE ELASTASE; LIPOPOLYSACCHARIDE; MACROPHAGE ELASTASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; MONOCYTE CHEMOTACTIC PROTEIN 3; NEUROPEPTIDE; NEUTROPHIL COLLAGENASE; ORGANOMERCURY COMPOUND; PEPTIDE; PLASMINOGEN; PLASMINOGEN ACTIVATOR; PLATELET DERIVED GROWTH FACTOR; PROSTAGLANDIN; PROTEIN; PROTEINASE; PROTEOGLYCAN; RECEPTOR; RNA; STROMELYSIN; STROMELYSIN 2; STROMELYSIN 3; THROMBOCYTE ACTIVATING FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TRYPSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UROKINASE;

ALLERGIC RHINITIS; ARTICLE; CHOLESTEATOMA; CHRONIC OTITIS MEDIA; DISEASE COURSE; DOWN REGULATION; ENZYME ACTIVATION; ENZYME SPECIFICITY; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEAD AND NECK CARCINOMA; HUMAN; IMMUNOCYTOCHEMISTRY; MAST CELL; MIDDLE EAR EFFUSION; NONHUMAN; NOSE POLYP; OTITIS MEDIA; PROTEIN EXPRESSION; SJOEGREN SYNDROME; UPREGULATION;

EAR DISEASES; HUMANS; MATRIX METALLOPROTEINASES; NOSE DISEASES; OTORHINOLARYNGOLOGIC DISEASES; SALIVARY GLAND DISEASES; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 21244449190     PISSN: 00222151     EISSN: None     Source Type: Journal    
DOI: 10.1258/0022215054273269     Document Type: Article

References (59)

1. Morimoto Y, Tsuda T, Nakamura H, Hori H, Yamato H, Nagata N, et al. Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases, and extracellular matrix mRNA following exposure to mineral fibers and cigarette smoke in vivo. Environ Health Perspect 1997;105(suppl 5):1247-51
2. Finlay GA, Russell KJ, McMahon KJ, D'arcy EM, Masterson JB, FitzGerald MX, et al. Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients. Thorax 1997;52:502-6
3. Nagase H, Ogata Y, Suzuki K, Enghild JJ, Salvesen G. Substrate specificities and activation mechanisms of matrix metalloproteinases. Biochem Soc Trans 1991;19:715-18
4. Stetler-Stevenson M, Mansoor A, Lim M, Fukushima P, Kehrl J, Marti G, et al. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells. Blood 1997;89:1708-15
5. Vaes G, Delaisse JM, Eeckhout Y. Relative roles of collagenase and lysosomal cysteine-proteinases in bone resorption. Matrix Suppl 1992;1:383-8
6. Parks WC, Wilson CL, Lopez-Boado YS. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 2004;4:617-29
7. Werner JA, Rathcke IO, Mandic R. The role of matrix metalloproteinases in squamous cell carcinomas of the head and neck. Clin Exp Metastasis 2002;19:275-82
8. Tokumaru Y, Fujii M, Otani Y, Kameyama K, Imanishi Y, Igarashi N, et al. Activation of matrix metalloproteinase-2 in head and neck squamous cell carcinoma: studies of clinical samples and in vitro cell lines co-cultured with fibroblasts. Cancer Lett 2000;150:15-21
9. Magary SP, Ryan MW, Tarnuzzer RW, Kornberg L. Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in laryngeal and pharyngeal squamous cell carcinoma: a quantitative analysis. Otolaryngol Head Neck Surg 2000;122:712-16
10. Kawamata H, Uchida D, Hamano H, Kimura-Yanagawa T, Nakashiro KI, Hino S, et al. Active-MMP2 in cancer cell nests of oral cancer patients: correlation with lymph node metastasis. Int J Oncol 1998;13:699-704
11. Corcoran ML, Hewitt RE, Kleiner DE Jr, Stetler-Stevenson WG. MMP-2: expression, activation and inhibition. Enzyme Protein 1996;49:7-19
12. Aimes RT, Quigley JP. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. J Biol Chem 1995;270:5872-6
13. Kelly EA, Jarjour NN. Role of matrix metalloproteinases in asthma. Curr Opin Pulm Med 2003;9:28-33
14. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001;17:463-516
15. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4:197-250
16. Van Wart HE, Birkedal-Hansen H. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Nat Acad Sci USA 1990;87:5578-82
17. Woessner JF Jr. MMPs and TIMPs - an historical perspective. Mol Biotechnol 2002;22:33-49
18. Edwards DR, Beaudry PP, Laing TD, Kowal V, Leco KJ, Leco PA, et al. The roles of tissue inhibitors of metalloproteinases in tissue remodelling and cell growth. Int J Obes Relat Metab Disord 1996;20(suppl 3):S9-15
19. McQuibban GA, Gong JH, Tam EM, McCulloch CA, Clark-Lewis I, Overall CM. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 2000;289:1202-6
20. Murphy G, Reynolds JJ, Bretz U, Baggiolini M. Partial purification of collagenase and gelatinase from human polymorphonuclear leucocytes. Analysis of their actions on soluble and insoluble collagens. Biochem J 1982;203:209-21
21. Hasty KA, Pourmotabbed TF, Goldberg GI, Thompson JP, Spinella DG, Stevens RM, et al. Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases. J Biol Chem 1990;265:11421-4
22. Shlopov BV, Lie WR, Mainardi CL, Cole AA, Chubinskaya S, Hasty KA. Osteoarthritic lesions: involvement of three different collagenases. Arthritis Rheum 1997;40:2065-74
23. Hanemaaijer R, Sorsa T, Konttinen YT, Ding Y, Sutinen M, Visser H, et al. Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline. J Biol Chem 1997;272:31504-9
24. Vincenti MP, Brinckerhoff CE. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res 2002;4:157-64
25. Brown PD, Kleiner DE, Unsworth EJ, Stetler-Stevenson WG. Cellular activation of the 72 kDa type IV procollagenase/TIMP-2 complex. Kidney Int 1993;43:163-70
26. Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 2000;14:163-76
27. Pruijt JF, Fibbe WE, Laterveer L, Pieters RA, Lindley IJ, Paemen L, et al. Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9). Proc Nat Acad Sci USA 1999;96:10863-8
28. Goldberg GI, Strongin A, Collier IE, Genrich LT, Marmer BL. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J Biol Chem 1992;267:4583-91
29. Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 1997;272:2446-51
30. Teufel P, Gotz F. Characterization of an extracellular metalloprotease with elastase activity from Staphylococcus epidermidis. J Bacteriol 1993;175:4218-24
31. Avidano MA, Cotter CS, Stringer SP, Schultz GS. Analysis of protease activity in human otitis media. Otolaryngol Head Neck Surg 1998;119:346-51
32. Albert J, Radomski A, Soop A, Sollevi A, Frostell C, Radomski MW. Differential release of matrix metalloproteinase-9 and nitric oxide following infusion of endotoxin to human volunteers. Acta Anaesthesiol Scand 2003;47:407-10
33. Jennings CR, Guo L, Collins HM, Birchall JP. Matrix metalloproteinases 2 and 9 in otitis media with effusion. Clin Otolaryngol 2001;26:491-4
34. Cotter CS, Avidano MA, Stringer SP, Schultz GS. Inhibition of proteases in Pseudomonas otitis media in chinchillas. Otolaryngol Head Neck Surg 1996;115:342-51
35. Antonelli PJ, Schultz GS, Kim KM, Cantwell JS, Sundin DJ, Pemberton PA, et al. Alpha 1-antitrypsin and ilomastat inhibit inflammatory proteases present in human middle ear effusions. Laryngoscope 2003;113:1347-51
36. Banerjee AR, James R, Narula AA, Lee RJ. Matrix metalloproteinase-1 in cholesteatoma, middle ear granulations and deep meatal skin: a comparative analysis. Clin Otolaryngol 1998;23:515-19
37. Schmidt M, Grunsfelder P, Hoppe F. Up-regulation of matrix metalloprotease-9 in middle ear cholesteatoma - correlations with growth factor expression in vivo? Eur Arch Otorhinolaryngol 2001;258:472-6
38. Schonermark M, Mester B, Kempf HG, Blaser J, Tschesche H, Lenarz T. Expression of matrix-metalloproteinases and their inhibitors in human cholesteatomas. Acta Otolaryngol 1996;116:451-6
39. Choufani G, Ghanooni R, Decaestecker C, Delbrouck K, Simon P, Schuring MP, et al. Detection of macrophage migration inhibitory factor (MIF) in human cholesteatomas and functional implications of correlations to recurrence status and to expression of matrix metalloproteinases-3/9, retinoic acid receptor-beta, and anti-apoptotic galectin-3. Laryngoscope 2001;111:1656-62
40. Onodera S, Kaneda K, Mizue Y, Koyama Y, Fujinaga M, Nishihira J. Macrophage migration inhibitory factor upregulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis. J Biol Chem 2000;275:444-50
41. Uhm JH, Dooley NP, Villemure JG, Yong VW. Mechanisms of glioma invasion: role of matrix-metalloproteinases. Can J Neurol Sci 1997;24:3-15
42. Wilmoth JG, Schultz GS, Antonelli PJ. Tympanic membrane metalloproteinase inflammatory response. Otolaryngol Head Neck Surg 2003;129:647-54
43. Lechapt-Zalcman E, Coste A, d'Ortho MP, Frisdal E, Harf A, Lafuma C, et al. Increased expression of matrix metalloproteinase-9 in nasal polyps. J Pathol 2001;193:233-41
44. Finotto S, Ohno I, Marshall JS, Gauldie J, Denburg JA, Dolovich J, et al. TNF-alpha production by eosinophils in upper airways inflammation (nasal polyposis). J Immunol 1994;153:2278-89
45. Larsen K, de Maat MP, Jespersen J. Plasminogen activators in human nasal polyps and mucosa. Rhinology 1997;35:175-7
46. Ohno I, Ohtani H, Nitta Y, Suzuki J, Hoshi H, Honma M, et al. Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. Am J Respir Cell Mol Biol 1997;16:212-19
47. Bellanti JA, Wallerstedt DB. Allergic rhinitis update: epidemiology and natural history. Allergy Asthma Proc 2000;21:367-7
48. Durham SR. The inflammatory nature of allergic disease. Clin Exp Allergy 1998;28(suppl 6):20-4
49. Opdenakker G, Van den Steen PE, Van Damme J. Gelatinase B: a tuner and amplifier of immune functions. Trends Immunol 2001;22:571-9
50. Kanbe N, Tanaka A, Kanbe M, Itakura A, Kurosawa M, Matsuda H. Human mast cells produce matrix metalloproteinase 9. Eur J Immunol 1999;29:2645-9
51. van Toorenenbergen AW, Gerth VW, Vermeulen AM. Allergen-induced matrix metalloproteinase-9 in nasal lavage fluid. Allergy 1999;54:293-4
52. Shaida A, Kenyon G, Devalia J, Davies RJ, MacDonald TT, Pender SL. Matrix metalloproteinases and their inhibitors in the nasal mucosa of patients with perennial allergic rhinitis. J Allergy Clin Immunol 2001;108:791-6
53. Kelly EA, Busse WW, Jarjour NN. Increased matrix metalloproteinase-9 in the airway after allergen challenge. Am J Respir Crit Care Med 2000;162:1157-61
54. Tanaka H, Miyazaki N, Oashi K, Tanaka S, Ohmichi M, Abe S. Sputum matrix metalloproteinase-9: tissue inhibitor of metalloproteinase-1 ratio in acute asthma. J Allergy Clin Immunol 2000;105:900-5
55. Hoshino M, Takahashi M, Takai Y, Sim J. Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. J Allergy Clin Immunol 1999;104:356-63
56. Perez P, Goicovich E, Alliende C, Aguilera S, Leyton C, Molina C, et al. Differential expression of matrix metalloproteinases in labial salivary glands of patients with primary Sjogren's syndrome. Arthritis Rheum 2000;43:2807-17
57. Wu AJ, Lafrenie RM, Park C, Apinhasmit W, Chen ZJ, Birkedal-Hansen H, et al. Modulation of MMP-2 (gelatinase A) and MMP-9 (gelatinase B) by interferon-gamma in a human salivary gland cell line. J Cell Physiol 1997;171:117-24
58. Konttinen YT, Halinen S, Hanemaaijer R, Sorsa T, Hietanen J, Ceponis A, et al. Matrix metalloproteinase (MMP)-9 type IV collagenase/gelatinase implicated in the pathogenesis of Sjogren's syndrome. Matrix Biol 1998;17:335-47
59. Brown PD. Matrix metalloproteinase inhibitors in the treatment of cancer. Med Oncol 1997;14:1-10